New study aims to combine imaging and genetics for smarter lung cancer care

NCT ID NCT05541744

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at whether combining PET scan images with genetic testing can better predict how well non-small cell lung cancer patients will respond to treatment and how long they might survive. Researchers will analyze scans and tumor samples from 120 adults. The goal is to create a more reliable tool for personalizing lung cancer care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a more accurate way to predict which lung cancer treatments will work best for each patient, improving personalized care.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly benefit participants. The findings may not lead to immediate changes in clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hualien Tzu Chi Hospital

    RECRUITING

    Hualien City, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.